Thomas Smith to Meningeal Neoplasms
This is a "connection" page, showing publications Thomas Smith has written about Meningeal Neoplasms.
Connection Strength
0.438
-
Lee V, Smith TW, Arikan M?, Zhang L, ?ataltepe O, ?ataltepe S. Fatty Acid-binding Protein 4 Expression in Tumor Cells as a Potential Marker for Anaplastic Meningiomas. Appl Immunohistochem Mol Morphol. 2021 02 01; 29(2):e10-e16.
Score: 0.176
-
Hao S, Smith TW, Chu PG, Liu Q, Ok CY, Woda BA, Lu D, Lin P, Wang SA, Dresser K, Rock KL, Jiang Z. The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma. Arch Pathol Lab Med. 2011 Aug; 135(8):1032-6.
Score: 0.091
-
Burrows AM, Smith TW, Hall WR, Pilitsis JG. Neurological picture. Ascending paralysis from malignant leptomeningeal melanomatosis. J Neurol Neurosurg Psychiatry. 2010 Apr; 81(4):449-50.
Score: 0.083
-
Salajegheh M, Rudnicki A, Smith TW. Expression of urokinase-type plasminogen activator receptor (uPAR) in primary central nervous system neoplasms. Appl Immunohistochem Mol Morphol. 2005 Jun; 13(2):184-9.
Score: 0.059
-
Wirth D, Smith TW, Moser R, Yaroslavsky AN. Demeclocycline as a contrast agent for detecting brain neoplasms using confocal microscopy. Phys Med Biol. 2015 Apr 07; 60(7):3003-11.
Score: 0.029